Title CCL 2 / CCR 2 augments the production of transforming growth factor-beta 1 , type 1 collagen and CCL 2 by human CD 45-/ collagen 1-positive cells under high glucose concentrations
暂无分享,去创建一个
S. Kaneko | R. Bucala | K. Matsushima | N. Mukaida | T. Wada | M. Takeya | Akinori Hara | N. Sakai | K. Furuichi | Y. Sakai | Y. Takuwa
[1] Hong Peng,et al. Fibrocytes: emerging effector cells in chronic inflammation. , 2012, Current opinion in pharmacology.
[2] S. Satchell,et al. Diabetic nephropathy. , 2012, Clinical medicine.
[3] S. Kaneko,et al. Clinical impact of albuminuria in diabetic nephropathy , 2012, Clinical and Experimental Nephrology.
[4] E. Hoffmann,et al. Osmosensory mechanisms in cellular and systemic volume regulation. , 2011, Journal of the American Society of Nephrology : JASN.
[5] J. Navarro-González,et al. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy , 2011, Nature Reviews Nephrology.
[6] S. Kaneko,et al. Involvement of bone-marrow-derived cells in kidney fibrosis , 2011, Clinical and Experimental Nephrology.
[7] S. Kaneko,et al. Fibrocytes are involved in the pathogenesis of human chronic kidney disease. , 2010, Human pathology.
[8] M. Burdick,et al. The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis , 2009, Journal of leukocyte biology.
[9] R. Gomer,et al. Identification of Markers that Distinguish Monocyte-Derived Fibrocytes from Monocytes, Macrophages, and Fibroblasts , 2009, PloS one.
[10] V. Stefanović,et al. Oxidative stress parameters as possible urine markers in patients with diabetic nephropathy. , 2009, Journal of diabetes and its complications.
[11] G. Camussi,et al. EFFECT OF THE MCP-1/CCR2 SYSTEM ON NEPHRIN EXPRESSION IN STREPTOZOTOCIN-TREATED MICE AND HUMAN CULTURED PODOCYTES , 2009 .
[12] Y. Hirata,et al. Role of CC Chemokine Receptor 2 in Bone Marrow Cells in the Recruitment of Macrophages into Obese Adipose Tissue* , 2008, Journal of Biological Chemistry.
[13] M. Kretzler,et al. From Fibrosis to Sclerosis , 2008, Diabetes.
[14] S. Kaneko,et al. The role of chemokines in glomerulonephritis. , 2008, Frontiers in bioscience : a journal and virtual library.
[15] S. Kaneko,et al. The renin–angiotensin system contributes to renal fibrosis through regulation of fibrocytes , 2008, Journal of hypertension.
[16] S. Kaneko,et al. Fibrocytes: a new insight into kidney fibrosis. , 2007, Kidney international.
[17] A. Bellini,et al. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses , 2007, Laboratory Investigation.
[18] P. Calder,et al. Glucose metabolism in lymphoid and inflammatory cells and tissues , 2007, Current opinion in clinical nutrition and metabolic care.
[19] E. Boutati,et al. Glucose transporter expression on the plasma membrane of resting and activated white blood cells , 2007, European journal of clinical investigation.
[20] S. Kaneko,et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis , 2006, Proceedings of the National Academy of Sciences.
[21] Yoshiya Tanaka,et al. Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus. , 2006, Biochemical and biophysical research communications.
[22] S. Kaneko,et al. MCP‐1/CCR2‐dependent loop for fibrogenesis in human peripheral CD14‐positive monocytes , 2006, Journal of leukocyte biology.
[23] M. Burdick,et al. Characterization of human fibrocytes as circulating adipocyte progenitors and the formation of human adipose tissue in SCID mice , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] T. Moore,et al. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. , 2005, The American journal of pathology.
[25] T. Wada,et al. Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[26] M. Burdick,et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. , 2004, The Journal of clinical investigation.
[27] 北川 清樹. Blockade of CCR2 ameliorates progressive fibrosis in kidney , 2004 .
[28] H. Takaishi,et al. High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cells. , 2003, Biochemical and biophysical research communications.
[29] M. A. Reddy,et al. High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. , 2003, Diabetes.
[30] A. Phillips,et al. Glucose-mediated induction of TGF-beta 1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent. , 2003, Kidney international.
[31] A. Phillips,et al. Differential Expression of Mcp-1 and Its Receptor CCR2 in Glucose Primed Human Mesangial Cells , 2002, Nephron.
[32] H. K. Lee,et al. Serum 8-hydroxy-guanine levels are increased in diabetic patients. , 2001, Diabetes care.
[33] K. Matsushima,et al. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. , 2000, Kidney international.
[34] M. Cooper,et al. Pathogenesis, prevention, and treatment of diabetic nephropathy , 1998, The Lancet.
[35] M. Kretzler,et al. Expression of glucose transporters in human peritoneal mesothelial cells. , 1998, Kidney international.
[36] K. Matsushima,et al. Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP‐1) , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[37] F. Numano,et al. Glucose-Dependent Interleukin 6 and Tumor Necrosis Factor Production by Human Peripheral Blood Monocytes In Vitro , 1996, Diabetes.
[38] C. Jung,et al. GLUT1 Transmembrane Glucose Pathway , 1996, The Journal of Biological Chemistry.
[39] R. Bucala,et al. Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair , 1994, Molecular medicine.